Management of Portal Hypertension.
J Clin Exp Hepatol
; 12(4): 1184-1199, 2022.
Article
em En
| MEDLINE
| ID: mdl-35814519
ACLF, acute-on-chronic liver failure; AKI, acute kidney injury; APRI, AST to platelet ratio; AST, aspartate transaminase; BB, Beta blocker; BRTO, balloon occluded retrograde transvenous obliteration; CKD, chronic kidney disease; CSPH, clinically significant portal hypertension; CT, computed tomography; GFR, glomerular filtration rate; GOV, gastrpoesopahegal varices; HE, hepatic encephalopathy; HRS, hepatorenal syndrome; HVPG, hepatic venous pressure gradient; ICG, indocyanine green; LOLA, l-ornithine l-aspartate; NAFLD, Non-alcoholic fatty liver disease; SBP, spontaneous bacterial peritonitis; SGLT2I, sodium glucose co-transporter 2 inhibitors; SSM, splenic stiffness measurement; TE, transient elastography; TIPS, transjugular intrahepatic portosystemic shunt; VITRO, von Willebrand factor to platelet counts; acute kidney injury; ascites; hemodynamics; history; vasoconstrictors
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article